TABLE 1.
Pediatric cohort (n = 16) |
Adult cohort (n = 9) |
||||
---|---|---|---|---|---|
EoE (11) | Controls (5) | EoE (4) | Controls (5) | ||
| |||||
Gender (n, % female) | 3 (27) | 2 (40) | 0 (0) | 4 (80) | |
Age (mean ± SD) | 9 ± 5 | 11 ± 5 | 37 ± 14 | 40 ± 16 | |
Multiple atopic diseases (n, %) | 3 (27) | 4 (80) | 2 (50) | 0 (0) | |
IgE-mediated food allergy | 3 (27) | 0 (0) | 2 (50) | 0 (0) | |
Asthma | 4 (36) | 2 (40) | 0 (0) | 0 (0) | |
Eczema | 4 (36) | 2 (40) | 0 (0) | 0 (0) | |
Rhinitis | 6 (55) | 4 (80) | 3 (75) | 0 (0) | |
PPI use (n, %) | 9 (82) | 3 (60) | 4 (100) | 4 (80) | |
Endoscopic phenotype (n, %) | |||||
Normal appearance | 4 (36) | 5 (100) | 0 (0) | 5 (100) | |
Inflammatory | 5 (45) | 0 (0) | 1 (25) | 0 (0) | |
Fibrostenotic | 2 (18) | 0 (0) | 3 (75) | 0 (0) | |
Milk-triggered | 7 | NA | 2 | NA | |
EoE (n) | |||||
Non-milk-triggered EoE (n) | 4 | NA | 2 | NA |